Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +54.01%
#3 Glidr Glidr +41.01%
#4 Cysic Cysic +38.33%
#5 Walrus Walrus +27.54%
#6 Humanity Humanity +25.25%
#7 Enso Enso +17.24%
#8 Tutorial Tutorial +15.94%
#9 The Black Bull The Black Bull +14.95%
#10 Codatta Codatta +14.84%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Clasificación en acciones #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Precio por acción
$0.069
Última sincronización: 2024-07-22
Capitalización bursátil
$2.06M
Cambio (1 día)
-1.43%
Cambio (1 año)
0.00%
País
US
Comercio DermTech, Inc. (DMTK)

Categoría

Healthcare
Ratio P/S de DermTech, Inc. (DMTK)
Ratio P/S al August 2026 TTM: 0.21
Según los informes financieros más recientes y el precio de las acciones de DermTech, Inc., el ratio P/S actual (TTM) es 0.21. Al final de 2022, el ratio P/S era 3.66.
Historial del ratio P/S de DermTech, Inc. desde 2016 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 0.21 -93.93%
2023 3.54 -3.27%
2022 3.66 -90.50%
2021 38.55 -58.81%
2020 93.59 262.47%
2019 25.82 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
4.72 2,095.53%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
5.67 2,537.74%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
16.40 7,529.83%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
9.55 4,341.69%
US